Sun Pharma Advanced Research Company Ltd - 532872 - Chairman'S Speech, Delivered At The 16Th Annual General Meeting Of The Company Held On September 29, 2021
Chairman''s speech is attached.29-09-2021
Sun Pharma Advanced Research Company Ltd - 532872 - Chairman'S Speech, Delivered At The 16Th Annual General Meeting Of The Company Held On September 29, 2021
Chairman''s speech is attached.SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
As per letter attached.Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Newspaper Publication
As per letter attachedSun Pharma Advanced Research Company Ltd - 532872 - Notice Of 16Th Annual General Meeting To Be Held On September 29, 2021
Annual Report for the FY ended March 31, 2021 along with Notice are attached.Sun Pharma Advanced Research Company Ltd - 532872 - Reg. 34 (1) Annual Report
Submission of Annual Report of the Company for the financial year ended March 31, 2021 and the Notice of 16th Annual General Meeting of the Company.Sun Pharma Advanced Research Company Ltd - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication under Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Notice Of Book Closure And Details Of 16Th Annual General Meeting Of Sun Pharma Advanced Research Company Limited ("The Company") For The Financial Year Ended March 31, 2021.
This is to inform you that, register of Members & Share Transfer Books of the Company will remain closed from 23-Sep-2021 to 29-Sep-2021 for the purpose of holding of 16th Annual General Meeting of the Company.SPARC seeks shareholders nod to raise up to Rs 1,800 crore
Sun Pharma Advanced Research Company (SPARC) on Wednesday said it will seek shareholders' approval to raise up to Rs 1,800 crore through various modes, including issue of equity shares and securities